NL930064I1 - Pharmaceutical preparation with antibacterial and beta-lactamase inhibitory activity as well as a heterocyclic five-ring condensed 2-azetidinone - Google Patents

Pharmaceutical preparation with antibacterial and beta-lactamase inhibitory activity as well as a heterocyclic five-ring condensed 2-azetidinone

Info

Publication number
NL930064I1
NL930064I1 NL930064C NL930064C NL930064I1 NL 930064 I1 NL930064 I1 NL 930064I1 NL 930064 C NL930064 C NL 930064C NL 930064 C NL930064 C NL 930064C NL 930064 I1 NL930064 I1 NL 930064I1
Authority
NL
Netherlands
Prior art keywords
azetidinone
antibacterial
heterocyclic
beta
well
Prior art date
Application number
NL930064C
Other languages
Dutch (nl)
Other versions
NL930064I2 (en
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=27122691&utm_source=***_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NL930064(I1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Pfizer filed Critical Pfizer
Publication of NL930064I1 publication Critical patent/NL930064I1/en
Publication of NL930064I2 publication Critical patent/NL930064I2/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D499/00—Heterocyclic compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. penicillins, penems; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/542—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/545—Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A61K31/429—Thiazoles condensed with heterocyclic ring systems
    • A61K31/43—Compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula, e.g. penicillins, penems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Oncology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
NL930064C 1977-06-07 1993-06-11 Pharmaceutical preparation with antibacterial and beta-lactamase inhibitory activity as well as with a heterocyclic five-ring condensed 2-azetidinone. NL930064I2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US80432077A 1977-06-07 1977-06-07
US87938178A 1978-02-21 1978-02-21

Publications (2)

Publication Number Publication Date
NL930064I1 true NL930064I1 (en) 1993-09-01
NL930064I2 NL930064I2 (en) 1994-04-18

Family

ID=27122691

Family Applications (2)

Application Number Title Priority Date Filing Date
NLAANVRAGE7806126,A NL180009C (en) 1977-06-07 1978-06-06 PHARMACEUTICAL PREPARATION WITH ANTI-BACTERIAL AND BETA-LACTAMASE INHIBITORY ACTION AND A HETEROCYCLIC FIVE CONDENSED 2-AZETIDINONE.
NL930064C NL930064I2 (en) 1977-06-07 1993-06-11 Pharmaceutical preparation with antibacterial and beta-lactamase inhibitory activity as well as with a heterocyclic five-ring condensed 2-azetidinone.

Family Applications Before (1)

Application Number Title Priority Date Filing Date
NLAANVRAGE7806126,A NL180009C (en) 1977-06-07 1978-06-06 PHARMACEUTICAL PREPARATION WITH ANTI-BACTERIAL AND BETA-LACTAMASE INHIBITORY ACTION AND A HETEROCYCLIC FIVE CONDENSED 2-AZETIDINONE.

Country Status (35)

Country Link
AR (1) AR224111A1 (en)
AT (2) AT360649B (en)
AU (1) AU513636B2 (en)
BE (1) BE867859A (en)
BG (2) BG34615A3 (en)
CH (1) CH634073A5 (en)
CS (1) CS208472B2 (en)
DD (2) DD148585A5 (en)
DE (2) DE2857263C3 (en)
DK (1) DK155740C (en)
EG (1) EG13869A (en)
FI (1) FI66003C (en)
FR (2) FR2393804A1 (en)
GB (1) GB2000138B (en)
GR (1) GR72255B (en)
HK (1) HK13184A (en)
HU (1) HU180042B (en)
IE (1) IE47079B1 (en)
IL (2) IL54867A (en)
IN (1) IN149747B (en)
IT (1) IT1096381B (en)
KE (1) KE3355A (en)
LU (1) LU79774A1 (en)
MY (1) MY8500092A (en)
NL (2) NL180009C (en)
NO (2) NO151746C (en)
NZ (1) NZ187476A (en)
OA (1) OA05964A (en)
PH (3) PH26810A (en)
PL (1) PL114501B1 (en)
PT (1) PT68146A (en)
SE (2) SE436206B (en)
SG (1) SG65383G (en)
SU (1) SU860706A1 (en)
YU (1) YU41829B (en)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
LU77306A1 (en) * 1977-05-09 1979-01-18
DE2912511C2 (en) * 1977-06-07 1982-06-24 Pfizer Inc., 10017 New York, N.Y. Pharmaceutical composition containing penicillanic acid
DK155942C (en) * 1977-12-23 1989-10-23 Pfizer METHOD OF ANALOGUE FOR THE PREPARATION OF 6-AMINOPENICILLANIC ACID-1,1-DIOXIDE AND PHYSIOLOGICALLY ACCEPTABLE ACID ADDITION AND BASIS SALTS.
JPS54126735A (en) * 1978-03-24 1979-10-02 Toyama Chem Co Ltd Bactericidal composition for medical use
US4241050A (en) * 1978-09-01 1980-12-23 Pfizer Inc. Penam 1,1-dioxides as beta-lactamase inhibitors
CA1158639A (en) * 1978-12-11 1983-12-13 Eric M. Gordon 6-bromopenicillanic acid sulfone
IE49881B1 (en) * 1979-02-13 1986-01-08 Leo Pharm Prod Ltd B-lactam intermediates
SE449103B (en) * 1979-03-05 1987-04-06 Pfizer SET TO PENICILLANIC ACID-1,1-DIOXIDE AND ESSERS THEREOF
US4420426A (en) 1979-03-05 1983-12-13 Pfizer Inc. 6-Alpha-halopenicillanic acid 1,1-dioxides
US4714761A (en) * 1979-03-05 1987-12-22 Pfizer Inc. 6,6-dihalopenicillanic acid 1,1-dioxides and process
GB2045236A (en) * 1979-03-26 1980-10-29 Hoechst Uk Ltd Oxapenem derivatives
US4244951A (en) 1979-05-16 1981-01-13 Pfizer Inc. Bis-esters of methanediol with penicillins and penicillanic acid 1,1-dioxide
US4309347A (en) * 1979-05-16 1982-01-05 Pfizer Inc. Penicillanoyloxymethyl penicillanate 1,1,1',1'-tetraoxide
IE49768B1 (en) * 1979-05-21 1985-12-11 Leo Pharm Prod Ltd 6beta-halopenicillanic acid derivatives
DE3051044C2 (en) * 1979-06-19 1989-03-30 Leo Pharmaceutical Products Ltd. A/S (Loevens Kemiske Fabrik Produktionsaktieselskab), Ballerup, Dk
US4256733A (en) * 1979-09-26 1981-03-17 Pfizer Inc. Acetoxymethyl penam compounds as β-lactamase inhibitors
US4432970A (en) * 1979-11-23 1984-02-21 Pfizer Inc. 6-beta-Halopenicillanic acid 1,1-dioxides as beta-lactamase inhibitors
IL61880A (en) * 1980-01-21 1984-11-30 Bristol Myers Co 2beta-chloromethyl-2alpha-methylpenam-3alpha-carboxylic acid sulfone derivatives,their preparation and pharmaceutical compositions containing them
US4432903A (en) * 1980-09-08 1984-02-21 Pfizer Inc. Bis-esters of methanediol with penicillins and penicillanic acid 1,1-dioxide
US4488994A (en) * 1980-09-08 1984-12-18 Pfizer Inc. Bis-esters of methanediol with penicillins and penicillanic acid 1,1-dioxide
US4474698A (en) * 1980-12-11 1984-10-02 Pfizer Inc. Process for preparing esters of penicillanic acid sulfone
US4419284A (en) * 1981-03-23 1983-12-06 Pfizer Inc. Preparation of halomethyl esters (and related esters) of penicillanic acid 1,1-dioxide
DE3261759D1 (en) * 1981-07-15 1985-02-14 Kanebo Ltd Novel ester of 1,1-dioxopenicillanic acid, process for production thereof, and use thereof as beta-lactamase inhibitor
PT76527B (en) * 1982-04-19 1985-12-09 Gist Brocades Nv A process for the preparation of penicillanic acid 1,1-dioxide and derivatives thereof
US4502988A (en) * 1983-08-08 1985-03-05 Eli Lilly And Company Oxidation process
EP0139047A1 (en) * 1983-10-18 1985-05-02 Gist-Brocades N.V. Process for the preparation of 6,6-dibromopenicillanic acid 1,1-dioxide
US4647457A (en) * 1983-12-16 1987-03-03 Hoffmann-La Roche Inc. Penicillanic acid derivatives
DE3780112T2 (en) * 1986-04-10 1992-12-24 Leo Pharm Prod Ltd METHOD FOR PRODUCING PENICILLANIC ACID DERIVATIVES.
GB8808701D0 (en) * 1988-04-13 1988-05-18 Erba Carlo Spa Beta-lactam derivatives
CN102977120B (en) * 2012-12-14 2015-05-27 江西富祥药业股份有限公司 Method for preparing and crystallizing sulbactam pivoxyl

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3197466A (en) * 1961-10-30 1965-07-27 Smith Kline French Lab Penicillin sulfoxides and process
LU77306A1 (en) * 1977-05-09 1979-01-18
EP0000636A1 (en) * 1977-07-13 1979-02-07 Glaxo Group Limited Penem compounds, processes for their preparation, their use in pharmaceutical compositions and azetidinones used in their preparation

Also Published As

Publication number Publication date
DK155740B (en) 1989-05-08
FI66003C (en) 1984-08-10
IE47079B1 (en) 1983-12-14
SE8305916L (en) 1983-10-27
NZ187476A (en) 1982-08-17
BG34614A3 (en) 1983-10-15
FR2393805B1 (en) 1984-02-24
IT1096381B (en) 1985-08-26
FR2393804B1 (en) 1980-11-07
SE7806628L (en) 1978-12-08
FI781800A (en) 1978-12-08
OA05964A (en) 1981-06-30
YU117078A (en) 1983-01-21
SE8305916D0 (en) 1983-10-27
DE2824535C3 (en) 1981-01-22
FR2393804A1 (en) 1979-01-05
PH26810A (en) 1992-11-05
NO781970L (en) 1978-12-08
PL114501B1 (en) 1981-02-28
PL207396A1 (en) 1979-06-04
DE2857263C3 (en) 1981-12-17
AU3683878A (en) 1979-12-06
SG65383G (en) 1985-03-29
BE867859A (en) 1978-12-06
DD140888A5 (en) 1980-04-02
IL54867A (en) 1981-11-30
IL62168A0 (en) 1981-03-31
CH634073A5 (en) 1983-01-14
IN149747B (en) 1982-04-03
IT7824270A0 (en) 1978-06-06
NL930064I2 (en) 1994-04-18
IE781140L (en) 1978-12-07
ATA128580A (en) 1981-02-15
SU860706A1 (en) 1981-08-30
AU513636B2 (en) 1980-12-11
HU180042B (en) 1983-01-28
DK155740C (en) 1989-10-23
MY8500092A (en) 1985-12-31
HK13184A (en) 1984-02-24
SE447995B (en) 1987-01-12
PT68146A (en) 1978-07-01
NO152448C (en) 1985-10-02
SE436206B (en) 1984-11-19
BG34615A3 (en) 1983-10-15
NL7806126A (en) 1978-12-11
GB2000138A (en) 1979-01-04
PH21116A (en) 1987-07-16
ATA411278A (en) 1980-06-15
DD148585A5 (en) 1981-06-03
EG13869A (en) 1983-03-31
DK251478A (en) 1978-12-08
FR2393805A1 (en) 1979-01-05
AR224111A1 (en) 1981-10-30
GB2000138B (en) 1982-03-03
DE2824535A1 (en) 1978-12-14
KE3355A (en) 1983-12-16
NO152448B (en) 1985-06-24
AT364084B (en) 1981-09-25
GR72255B (en) 1983-10-06
AT360649B (en) 1981-01-26
PH16465A (en) 1983-10-20
NO823126L (en) 1978-12-08
CS208472B2 (en) 1981-09-15
IL54867A0 (en) 1978-08-31
NO151746B (en) 1985-02-18
DE2857263B2 (en) 1981-04-23
LU79774A1 (en) 1980-01-22
YU41829B (en) 1988-02-29
FI66003B (en) 1984-04-30
NL180009C (en) 1986-12-16
NO151746C (en) 1985-06-05
DE2824535B2 (en) 1980-05-14

Similar Documents

Publication Publication Date Title
NL930064I1 (en) Pharmaceutical preparation with antibacterial and beta-lactamase inhibitory activity as well as a heterocyclic five-ring condensed 2-azetidinone
NL183358C (en) PHARMACEUTICAL PREPARATION AND PENICILLANIC ACID DERIVATIVE USED THEREIN WITH BETA-LACTAMASE INHIBITORY EFFECT.
AT368357B (en) HERBICIDAL AGENTS
NL190554C (en) Cephalosporin derivative, and pharmaceutical or veterinary preparation with antibacterial activity, containing this cephalosporin derivative.
DE3682711D1 (en) HETEROCYCLIC COMPOUNDS TO BE USED AS FUNGICIDES.
AT366883B (en) HERBICIDAL AGENTS
NL185622C (en) PHARMACEUTICAL PREPARATION WITH ANTIBACTERIAL ACTION, AND 7BETA-ACYLAMINO-7ALFA-METHOXY-3-HETEROCYCLYLTHIOMETHYL-3-CEFEM-4-CARBONIC ACID.
NL7805717A (en) POLYPEPTIDES WITH MEDICINE ACTIVITY.
DD137822A5 (en) HERBICIDAL AGENTS CONTAINING DIURETHANE
NL173750C (en) PHARMACEUTICAL PREPARATION WITH PROSTAGLANDINE ANTAGONISTIC ACTION AND USEFUL MONOCYCLIC ORGANIC COMPOUNDS USED THEREIN.
BE871162R (en) DRILLING UNIT
NL185923B (en) PHARMACEUTICAL PREPARATION WITH ANTIBACTERIAL ACTION, AND PENAM-3-CARBONIC ACID-1,1-DIOXIDE DERIVATIVE.
NL190632C (en) Oxadethiacephalosporins and drug with antibacterial effect.
DK302888D0 (en) PESTICIDE HETEROCYCLIC COMPOUNDS
DK486478A (en) ANTIBACTERIAL ACTIVE COMPOUNDS
IT7821748A0 (en) PS-5 ANTIBIOTIC AND ITS DERIVATIVES HAVING BETA-LACTAMASE INHIBITORY ACTIVITY AND THEIR PRODUCTION.
NL7604281A (en) AZETIDINONES WITH ANTIBACTERIAL ACTIVITY.
NL7806163A (en) PHARMACEUTICAL PREPARATION WITH ANTI-BACTERIAL ACTION.
FR2289188A1 (en) AZETIDINONES SUBSTITUTED WITH ANTIBACTERIAL ACTIVITY
NO146955C (en) N-HYDROXY-N-PHOSPHONOMETHYL COMPOUND WITH IMPROVED HERBICID ACTIVITY.
NL7811247A (en) DRUG HEAD.
AT365406B (en) HERBICIDAL AGENTS
AT364191B (en) HERBICIDAL AGENTS
AT357362B (en) HERBICIDAL AGENTS
NL7806859A (en) COMPOUNDS WITH ANTIBIOTIC ACTIVITY.